Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.710
-0.030 (-1.09%)
At close: Nov 14, 2025, 4:00 PM EST
2.758
+0.048 (1.79%)
After-hours: Nov 14, 2025, 7:26 PM EST
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $123.75 million as of November 14, 2025. Its market cap has increased by 80.25% in one year.
Market Cap
123.75M
Enterprise Value
113.09M
1-Year Change
80.25%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $123.75M, an increase of 72.42%. That is a compound annual growth rate of 7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 125.12M | 60.23% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | 19.83M | -23.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |